Medication reference
Promethazine
Monograph awaiting updateThis monograph will be updated in the future.
Review note before using historical content
Promethazine historical concentration and infusion advice is superseded
The restored article already warns against IV push, but other concentration and infusion-time examples conflict with the later FDA labeling update. Deep intramuscular administration is preferred; if IV administration is necessary, follow the updated exact-product dilution and infusion instructions. Do not use the old maximum-IV-concentration sentence or infusion examples as current instructions.
Safety sources and review scope
- FDA class-wide promethazine labeling safety update (opens in a new tab)Source URL: https://www.fda.gov/drugs/drug-alerts-and-statements/fda-requires-updates-labeling-promethazine-hydrochloride-injection-products
Exact location: 2023-12-27 notice: administration recommendation paragraph; If intramuscular injection is not possible bullets; adult and pediatric dilution/infusion tables
Source family: FDA class-wide promethazine labeling safety update
Scope: Official route/concentration/administration update; not a complete individual product monograph.
- Promethazine U.S. prescribing information implementing FDA update (opens in a new tab)Source URL: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d02d52b-84bb-4e81-b352-125029eb39f6
Exact location: CONTRAINDICATIONS UUID0e9dd230-b07d-cda7-e063-6394a90ae084; DOSAGE AND ADMINISTRATION UUID0eade268-8023-e418-e063-6294a90a6ff9, Important Administration Information and Preparation/Administration for Diluted IV Infusion, Tables1/2
Source family: Promethazine U.S. prescribing information implementing FDA update
Scope: Example updated SPL version8 effective2024-01-05. It confirms the label change; stocked manufacturer/package and latest marketing status remain unreconciled.
Historical source in disagreement: Archived GlobalRPh article (opens in a new tab)Historical source URL: https://globalrph.com/dilution/promethazine/
Historical location: Drug Dilution:15–30 minute examples; Stability/Miscellaneous: Limit concentration paragraph and historical ISMP strategies
Review-note ID: H62-SAFETY-PROMETHAZINE-ADMINISTRATION. The historical source remains preserved; this note does not qualify its complete monograph.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Promethazine (opens in a new tab)Original source URL: https://globalrph.com/dilution/promethazine/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/promethazine/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:47:24.201827+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- 2dd4f01d4b5b9cebbd4a0fc3532d9ab8b2a155ba12f47798a9daf216ea448069
- Original response SHA-256
- 8356be5791a8cf5f99a89fc495f637c3dd450f1a5d5c268ed747f78741912194
- Source body SHA-256
- c675d139591292ad2d9f3b480197f6042ee80945fbf2ea8ee47cfdacaa9fec3f
Promethazine |
|
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. | |
Usual Diluents |
|
| NS, D5W | |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]Promethazine historical concentration and infusion advice is superseded The restored article already warns against IV push, but other concentration and infusion-time examples conflict with the later FDA labeling update. Deep intramuscular administration is preferred; if IV administration is necessary, follow the updated exact-product dilution and infusion instructions. Do not use the old maximum-IV-concentration sentence or infusion examples as current instructions. |
|
| Follow your local protocol.... Detroit VAMC Dilution: [0 - 25 mg] [ 50 -100 ml] [ 15 - 30 min] Concentration studied in Trissel: (0.1 mg/ml) |
|
Stability / MiscellaneousPromethazine historical concentration and infusion advice is superseded The restored article already warns against IV push, but other concentration and infusion-time examples conflict with the later FDA labeling update. Deep intramuscular administration is preferred; if IV administration is necessary, follow the updated exact-product dilution and infusion instructions. Do not use the old maximum-IV-concentration sentence or infusion examples as current instructions. |
|
| EXP: 1 DAY (RT) Label: Do not Refrigerate. Protect from light.
Dilution opinion (D. McAuley): Antiemetic: Oral, I.M., I.V., rectal: 12.5 to 25 mg every 4 to 6 hours as needed. -------------------------------------------------------------------------------- Background information: Title: Action needed to prevent serious tissue injury with IV promethazine. "ISMP believes these long-standing hazards require further action on the part of healthcare providers, FDA, and promethazine manufacturers. In the 1970s, after numerous reports of infiltration and inadvertent intraarterial injection of hydroxyzine, FDA asked the manufacturer to revise the label and remove IV as an approved route. Today the drug is only indicated for IM or oral administration. Similarly, FDA should carefully investigate adverse events with this drug to determine if labeling changes are warranted, including removal of approval for IV administration." Safe Practice Recommendations: ... [See ISMP for further info ] Limited direct quotes from this source. Along with the manufacturer recommendations, the following strategies should be considered to prevent or minimize tissue damage when giving IV promethazine.... [See ISMP for further info ] Limit concentration. Since 25 mg/mL is the highest concentration of promethazine that can be given IV, stock only this concentration (not the 50 mg/mL concentration). Limit the dose. Consider 6.25 to 12.5 mg of promethazine as the starting IV dose, especially for elderly patients. Hospitals have reported that these smaller doses have proven quite effective. Dilute the drug. Require further dilution of the 25 mg/mL strength to reduce vesicant effects and enable slow administration. For example, dilute the drug in 10 to 20 mL of normal saline if it will be administered via a running IV, or prepare the medication in minibags containing normal saline if there is time for pharmacy to dispense them as needed for individual patients. Extravasation can also be recognized more quickly when promethazine is diluted than if the drug is given in a smaller volume. Use large patent veins. Give the medication only through a large-bore vein (preferably via a central venous access site, but absolutely no hand or wrist veins). Check patency of the access site before administration... [See ISMP for further info ] Inject into the furthest port. Administer IV promethazine through a running IV line at the port furthest from the patient's vein. Educate patients. Before administration of the drug, tell patients to let you know immediately if burning or pain occurs during or after the injection. Use alternatives. Consider safer alternatives that can be used for the various conditions treated with IV promethazine. For example, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists may be used for both prophylaxis and as a rescue antiemetic. ... [See ISMP for further info ] Remove from formulary. Some hospitals that have continued to experience adverse outcomes despite safety measures have removed promethazine from their formulary or banned its IV use.The above message comes from "ISMP", who is solely responsible for its content. Nursing forum responses (Various sources - original sources unknown) -------------------------------------------------------------------------------- "Mosby's drug guide for nurses states to dilute with 9ml NaCl and administer over 2 minutes. Always dilute phenergan when giving it IV. My DH was in ER a while ago for what turned out to be food poisoning, they gave him undiluted phenergan and his vein sclerosed from wrist to bicep (no I'm NOT exaggerating)" -------------------------------------------------------------------------------- "As a nurse, I have had many patients complain aobut how much Phenergan burns. I would always just politely tell them them that it would burn and then push it slow diluted in 10 cc's of NS but then it was my turn. I was hospitalized and was given IV Phenergan and it not only burned like heck but I swear I felt like I was having a full blown MI. My entire arm was numb not to mention the IV site had to be changed and I developed phlebitis all around the site. I don't give Phenergan anymore without diluting it in 50 cc's of NS. I learned my lesson." |
FDA safety resources for this medication (1)
Read the linked communication and current prescribing information before use. Resource dates and affected product scopes differ; a listed resource is not a full monograph or a lot-specific clearance.
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- promethazine
Source ID
H51-810DDF5B67158F7ED036FBAA - Generic name
- Promethazine
Source ID
H51-7DB381B540D1C0CF7E5DDC18 - Class
- GI and antiemetic
Source ID
H51-5D3C1A80C2A601CDCEFAC265 - Subclass
- Legacy GlobalRPh directory entry
Source ID
H51-668BC49E4171521ECD0628A9 - Primary uses
- Acid suppression, nausea and vomiting control, or gastrointestinal motility therapy, depending on the named agent.
Source ID
H51-5EBA6B8C15C7885D8052EA8B
- Acid suppression, nausea and vomiting control, or gastrointestinal motility therapy, depending on the named agent.
- Mechanism
- Blocks histamine H1 receptors and also has antimuscarinic and antidopaminergic effects.
Source ID
H51-6446960CC82CE635941D055F - Mechanism level
- drug_specific
Source ID
H51-3442D4737BC7BC65C636F3F7 - Basic dosing orientation
- The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy.
Source ID
H51-7BA7E0C04517C459ED20B6F3 - Administration orientation
- Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required.
Source ID
H51-368C53A2D122590C52DACC1E - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-96F0262C3BA213AA926013F8 - Key safety orientation
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-82105DE00B40B1C4971BAB8B
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
- Coverage path
- automatic_legacy_quick_reference
Source ID
H51-E90A3C9D04A477E45EC3C01E - Coverage path label
- Automatic legacy GlobalRPh quick reference
Source ID
H51-ED97FE6366162DFC3E7189C9 - Legacy title
- Promethazine
Source ID
H51-C0FD181ABA32E3A090EE6A00 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-0C80C29C9209EDABD9C737C0 - Search text
- Promethazine GI and antiemetic Legacy GlobalRPh directory entry Acid suppression, nausea and vomiting control, or gastrointestinal motility therapy, depending on the named agent. Blocks histamine H1 receptors and also has antimuscarinic and antidopaminergic effects. The existing GlobalRPh dose and preparation quick reference loads automatically below. Treat it as historical continuity, then confirm the exact current DailyMed label, population, indication, renal function, and institutional policy. Route, dilution, concentration, and administration details load automatically from the existing GlobalRPh quick reference below; current exact-product verification remains required. Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Automatic legacy GlobalRPh quick reference
Source ID
H51-E19BF844E12A080CEAE11CD3 - Official access mode
- none
Source ID
H51-761F81B5DDAA92A0098FB1B1 - Official access reason
- No source-backed DailyMed action has been verified for this umbrella or legacy record; identify the exact product before searching.
Source ID
H51-67C225361578BD98DAFAC6B0
No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-328A510E466A5528FB8499DA - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-01879F875057619C61631CDA - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-CFBC4007F73C250058CB6B33
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-B13EFC8290F86BF3A4776BFC
Historical Stability notes
Recovered v5.1 source content; historical, awaiting current review.
- Legacy product stability information is not automatically equivalent to a USP <797> BUD.
Source ID
H51-2B52E4EDB4EC64766368E0FF
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
promethazineSource ID
H51-2F56692F1191C1B5E8FE788ELegacy title
PromethazineSource ID
H51-9215BB74AB5FD401C21E51B8Generic name
PromethazineSource ID
H51-3CDF6F903495AFE79895313AClass
GI and antiemeticSource ID
H51-C70A68B97B657DDA017BA12ASubclass
Legacy GlobalRPh directory entrySource ID
H51-F5DBEAEBBA5405925F5A7575Summary
Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.Source ID
H51-F837F497BEF5DE620C691B54Populations
- Population not yet normalized
Source ID
H51-1AFA90EF23997773F65748B7
Evidence tier
Legacy catalog - migration review requiredSource ID
H51-85F7E3FE804FE9FF28438525High alert
falseSource ID
H51-F087FEF73236BBD21B27AED3Hazardous
falseSource ID
H51-E5DFC97055BF861E0059D803Status
Legacy migrationSource ID
H51-F99DF1C09327E77BC5FDC2D3Version added
LegacySource ID
H51-2785E74E6CFF335A2DFD6BC4Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-DBB4C199D358F91C25EAD704Source IDH51-37554F3529DC15989D07EBC1 | legacy:autoSource IDH51-5027CA53FA326BFFC11A0815 | LegacySource IDH51-8E7F400A3E2A50B721D89BB9 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-38B849E3A355D80649941038 - Audited on
- 2026-08-30
Source ID
H51-785C5EFCF9142A7B4559E31C - Level
- red
Source ID
H51-B67CB7CC5DE94FB3D0EA0DFE - Release gate
- unverified_or_unclassified_sources_do_not_release_as_current
Source ID
H51-CC5EA8E6942DF85F0290FF74 - Exact current label candidate
- false
Source ID
H51-1728472602389F49617E5F2E - Reference url count
- 0
Source ID
H51-BFC1474149C1D80903943761 - Broken reference count
- 0
Source ID
H51-3B500BEB0F3E9AA0B53A39D3 - Point of use confirmation required
- true
Source ID
H51-93B9078B358EA834A44C337E - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-3B75874EC21F66818A691D5D - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Promethazine (opens in a new tab)
Source ID
H51-AB7AC9923883098E60146D11
Dosing source fields
Id
promethazineSource ID
H51-40EDC2203BB2BA8128E1536AGeneric name
PromethazineSource ID
H51-5D1C8EAD3B1D44C68A69F89CCoverage status
direct_official_label_access_plus_legacy_referenceSource ID
H51-5EBB38FB90F3E9B1B07CBAA1Package insert
- Query name
- Promethazine
Source ID
H51-A423BF40BF722B31A9049C5C - Product and route must match
- true
Source ID
H51-FE8F7687AD8E894DAF5EED8E - Live current label enabled
- false
Source ID
H51-10F4850FF61B948326EB9163 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-12DD83EC2EDDD299922C2D2D - Direct official label access enabled
- true
Source ID
H51-D6402C192731310202E8DE6F - Outbound server request required
- false
Source ID
H51-021D0DB33D500472A01AF185 - Local summary status
- not_bundled
Source ID
H51-D1000FF200CD325B46229EA5
Clinical review
- Locally normalized
- false
Source ID
H51-6AD1C0B728E328A672F90794 - Reviewed
- 2026-08-29
Source ID
H51-78FE8D3EF2142DAE2F968BD6 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-2FA576226C1400CD6AF2802B
Clinical release verification
- Audit version
- 3.4
Source ID
H51-2F37F9844D9F48C5115A6D5A - Audited on
- 2026-08-30
Source ID
H51-6A92DFD3F250A6556D0E5B61 - Level
- red
Source ID
H51-22CBB0B0CD0C7D1C195B8659 - Release gate
- unverified_or_unclassified_sources_do_not_release_as_current
Source ID
H51-7F2741195BD7AB36274CF515 - Exact current label candidate
- false
Source ID
H51-087C4A5C459E9B4CBD34146E - Reference url count
- 0
Source ID
H51-41D8180A71BA0060DD045F6B - Broken reference count
- 0
Source ID
H51-B0A090F71AC795BEF7564F1A - Point of use confirmation required
- true
Source ID
H51-060C405B3A1690D4529EBDB0 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-645E9494ECD600A76F439BA0 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Promethazine (opens in a new tab)
Source ID
H51-EFC60139CB4619FF19DB4A0A
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- promethazine
Source ID
H51-157BA35A65DF37EEF194C665 - Name
- Promethazine
Source ID
H51-3277DFD72ED20CD73B483609 - Therapeutic class
- GI and antiemetic
Source ID
H51-7925ADE6FCA0CE78267CDD0D - Review version
- 3.1
Source ID
H51-3159DD2563E9F01EDED9414D - Review date
- 2026-08-30
Source ID
H51-924938BD41DDFD6C1B401AD3 - Release status
- no_released_dilution_current_label_review_required
Source ID
H51-E4BFC3E49988DDB6CE44D20F - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-7D270AA42F5E6029B7EA72C8 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-97117D3F7A990B3131AA3585
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-175B333F55C103320B06E6C4 - Reconstitution concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-40CC807AEB628042B41153F8 - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-9E131B8EE17597D0F3545FB6 - Appropriate standardized containers
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-41AEA531AC7271691ADFC0A1 - Adult dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-A3955D0FAF10AF27002E5E33 - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-0E866F8AF0D3D77413C44EA3 - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-714C0F65E041970523F88D3E - Infusion time
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-DF9704F08687F3E6F03E813E - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-7ADCC0F70A6B2E7CB1649120 - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-D94B86B9EE01BC5FBB45098B - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Promethazine (opens in a new tab)
Source ID
H51-65BA2147BE3EE7721260CA31
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-E3DC6035FF0A975FB63F4962
- Reconstitution concentration
- Primary
- not_found
Source ID
H51-DEC81D90E4D4795C2F99937E
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-8B034038C0B3CC6B2D9A3A93
- Appropriate standardized containers
- Primary
- not_found
Source ID
H51-31B9D77F47A729CAD885EA5B
- Adult dosing range
- Primary
- not_found
Source ID
H51-F2AF8C2964039283D4A4D630
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-7912A2EAF8A93ED83FC64E0A
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-53D55403C00A8F2F5A987B0F
- Infusion time
- Primary
- not_found
Source ID
H51-37240E82186C80118C1FEEB6
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-DFA9E0445E47288690BC1156
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-E6F6C00791E703B5B90BBDCE
- Population applicability
- Adult
- Applicability
- not_established
Source ID
H51-97CA7E077F04493D69C1A37F - Guide generation allowed
- false
Source ID
H51-99CC1B3741CE666AE3897C2B
- Pediatric
- Applicability
- not_established
Source ID
H51-069899991D4078B7A099535A - Guide generation allowed
- false
Source ID
H51-095AD054B622970CB1B655F9
- Neonatal
- Applicability
- not_established
Source ID
H51-A4272E745D8E701D4FB036F9 - Guide generation allowed
- false
Source ID
H51-7500756804D22799C4B5DCBC
- Route presence
- Structured dilution
- false
Source ID
H51-E480D233101C5B50561B13A8 - Iv push
- false
Source ID
H51-A4363F5F789E98F189EAAB7F - Continuous infusion
- false
Source ID
H51-D2DD6CE54324F2D5E4FDB822 - Pediatric source
- false
Source ID
H51-EBB02ADECC938BF73F495ACB - Neonatal source
- false
Source ID
H51-D3B99D89070FFA157ED90545
- Legacy reference
- Status
- not_available
Source ID
H51-B4664D400F522E00310CD7BC
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-9AE9446F28447BCDE9213902
- Source files
- catalog.json
Source ID
H51-56FB6F560A8516EEFB5A560B - dosing.json
Source ID
H51-D03CEDD2D9CD62B7B078F886 - legacy-map.json
Source ID
H51-A28385F57DA1A9E4602EFD46 - review-queue.json
Source ID
H51-994E710DF0FD6554E70FA1D9
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-EABF9F008C51E1C179F0E746
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-2F56692F1191C1B5E8FE788E | catalog.json/records/207/id | Historical; current review incomplete |
H51-9215BB74AB5FD401C21E51B8 | catalog.json/records/207/legacy_title | Historical; current review incomplete |
H51-3CDF6F903495AFE79895313A | catalog.json/records/207/generic_name | Historical; current review incomplete |
H51-C70A68B97B657DDA017BA12A | catalog.json/records/207/class | Historical; current review incomplete |
H51-F5DBEAEBBA5405925F5A7575 | catalog.json/records/207/subclass | Historical; current review incomplete |
H51-F837F497BEF5DE620C691B54 | catalog.json/records/207/summary | Historical; current review incomplete |
H51-B13EFC8290F86BF3A4776BFC | catalog.json/records/207/warnings/0 | Historical; current review incomplete |
H51-2B52E4EDB4EC64766368E0FF | catalog.json/records/207/stability_notes/0 | Historical; current review incomplete |
H51-1AFA90EF23997773F65748B7 | catalog.json/records/207/populations/0 | Historical; current review incomplete |
H51-85F7E3FE804FE9FF28438525 | catalog.json/records/207/evidence_tier | Historical; current review incomplete |
H51-F087FEF73236BBD21B27AED3 | catalog.json/records/207/high_alert | Historical; current review incomplete |
H51-E5DFC97055BF861E0059D803 | catalog.json/records/207/hazardous | Historical; current review incomplete |
H51-F99DF1C09327E77BC5FDC2D3 | catalog.json/records/207/status | Historical; current review incomplete |
H51-3E3BE2F8D19A8BF9519CBD41 | catalog.json/records/207/reviewed | Historical; current review incomplete |
H51-2785E74E6CFF335A2DFD6BC4 | catalog.json/records/207/version_added | Historical; current review incomplete |
H51-DBB4C199D358F91C25EAD704 | catalog.json/records/207/sources/0 | Historical; current review incomplete |
H51-37554F3529DC15989D07EBC1 | catalog.json/records/207/sources/0/label | Historical; current review incomplete |
H51-5027CA53FA326BFFC11A0815 | catalog.json/records/207/sources/0/url | Historical; current review incomplete |
H51-8E7F400A3E2A50B721D89BB9 | catalog.json/records/207/sources/0/kind | Historical; current review incomplete |
H51-38B849E3A355D80649941038 | catalog.json/records/207/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-785C5EFCF9142A7B4559E31C | catalog.json/records/207/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-B67CB7CC5DE94FB3D0EA0DFE | catalog.json/records/207/clinical_release_verification/level | Historical; current review incomplete |
H51-CC5EA8E6942DF85F0290FF74 | catalog.json/records/207/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-1728472602389F49617E5F2E | catalog.json/records/207/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-62F16532A5FEAA75E472C9C6 | catalog.json/records/207/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-BE4BA23EF771B4C9F89CA69F | catalog.json/records/207/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-80F22772F7A429F6DD7DA408 | catalog.json/records/207/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-BFC1474149C1D80903943761 | catalog.json/records/207/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-3B500BEB0F3E9AA0B53A39D3 | catalog.json/records/207/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-93B9078B358EA834A44C337E | catalog.json/records/207/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-3B75874EC21F66818A691D5D | catalog.json/records/207/clinical_release_verification/note | Historical; current review incomplete |
H51-AB7AC9923883098E60146D11 | catalog.json/records/207/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-40EDC2203BB2BA8128E1536A | dosing.json/records/207/id | Historical; current review incomplete |
H51-5D1C8EAD3B1D44C68A69F89C | dosing.json/records/207/generic_name | Historical; current review incomplete |
H51-5EBB38FB90F3E9B1B07CBAA1 | dosing.json/records/207/coverage_status | Historical; current review incomplete |
H51-A423BF40BF722B31A9049C5C | dosing.json/records/207/package_insert/query_name | Historical; current review incomplete |
H51-A39A13A2D4CDDEFB4DC42557 | dosing.json/records/207/package_insert/preferred_setid | Historical; current review incomplete |
H51-FE8F7687AD8E894DAF5EED8E | dosing.json/records/207/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-10F4850FF61B948326EB9163 | dosing.json/records/207/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-12DD83EC2EDDD299922C2D2D | dosing.json/records/207/package_insert/source_priority | Historical; current review incomplete |
H51-D6402C192731310202E8DE6F | dosing.json/records/207/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-021D0DB33D500472A01AF185 | dosing.json/records/207/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-D1000FF200CD325B46229EA5 | dosing.json/records/207/package_insert/local_summary_status | Historical; current review incomplete |
H51-328A510E466A5528FB8499DA | dosing.json/records/207/renal/classification | Historical; current review incomplete |
H51-01879F875057619C61631CDA | dosing.json/records/207/renal/summary | Historical; current review incomplete |
H51-CFBC4007F73C250058CB6B33 | dosing.json/records/207/renal/method_note | Historical; current review incomplete |
H51-6AD1C0B728E328A672F90794 | dosing.json/records/207/clinical_review/locally_normalized | Historical; current review incomplete |
H51-78FE8D3EF2142DAE2F968BD6 | dosing.json/records/207/clinical_review/reviewed | Historical; current review incomplete |
H51-2FA576226C1400CD6AF2802B | dosing.json/records/207/clinical_review/status | Historical; current review incomplete |
H51-2F37F9844D9F48C5115A6D5A | dosing.json/records/207/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-6A92DFD3F250A6556D0E5B61 | dosing.json/records/207/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-22CBB0B0CD0C7D1C195B8659 | dosing.json/records/207/clinical_release_verification/level | Historical; current review incomplete |
H51-7F2741195BD7AB36274CF515 | dosing.json/records/207/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-087C4A5C459E9B4CBD34146E | dosing.json/records/207/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-D1649854A54ADE72294AE0B9 | dosing.json/records/207/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-40E511981E60167C8E204335 | dosing.json/records/207/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-C303351CE80B4A571B2C58F1 | dosing.json/records/207/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-41D8180A71BA0060DD045F6B | dosing.json/records/207/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-B0A090F71AC795BEF7564F1A | dosing.json/records/207/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-060C405B3A1690D4529EBDB0 | dosing.json/records/207/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-645E9494ECD600A76F439BA0 | dosing.json/records/207/clinical_release_verification/note | Historical; current review incomplete |
H51-EFC60139CB4619FF19DB4A0A | dosing.json/records/207/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-810DDF5B67158F7ED036FBAA | first-look-v5.1.json/records/207/id | Historical; current review incomplete |
H51-7DB381B540D1C0CF7E5DDC18 | first-look-v5.1.json/records/207/generic_name | Historical; current review incomplete |
H51-5D3C1A80C2A601CDCEFAC265 | first-look-v5.1.json/records/207/class | Historical; current review incomplete |
H51-668BC49E4171521ECD0628A9 | first-look-v5.1.json/records/207/subclass | Historical; current review incomplete |
H51-5EBA6B8C15C7885D8052EA8B | first-look-v5.1.json/records/207/primary_uses/0 | Historical; current review incomplete |
H51-6446960CC82CE635941D055F | first-look-v5.1.json/records/207/mechanism | Historical; current review incomplete |
H51-3442D4737BC7BC65C636F3F7 | first-look-v5.1.json/records/207/mechanism_level | Historical; current review incomplete |
H51-7BA7E0C04517C459ED20B6F3 | first-look-v5.1.json/records/207/basic_dosing_orientation | Historical; current review incomplete |
H51-368C53A2D122590C52DACC1E | first-look-v5.1.json/records/207/administration_orientation | Historical; current review incomplete |
H51-96F0262C3BA213AA926013F8 | first-look-v5.1.json/records/207/renal_and_population_orientation | Historical; current review incomplete |
H51-82105DE00B40B1C4971BAB8B | first-look-v5.1.json/records/207/key_safety_orientation/0 | Historical; current review incomplete |
H51-E90A3C9D04A477E45EC3C01E | first-look-v5.1.json/records/207/coverage_path | Historical; current review incomplete |
H51-ED97FE6366162DFC3E7189C9 | first-look-v5.1.json/records/207/coverage_path_label | Historical; current review incomplete |
H51-CCDD0B572E36D049C5C49E2A | first-look-v5.1.json/records/207/official_label_url | Historical; current review incomplete |
H51-C0FD181ABA32E3A090EE6A00 | first-look-v5.1.json/records/207/legacy_title | Historical; current review incomplete |
H51-0C80C29C9209EDABD9C737C0 | first-look-v5.1.json/records/207/review_note | Historical; current review incomplete |
H51-E19BF844E12A080CEAE11CD3 | first-look-v5.1.json/records/207/search_text | Historical; current review incomplete |
H51-1751CA30B067194255927B2F | first-look-v5.1.json/records/207/official_search_url | Historical; current review incomplete |
H51-761F81B5DDAA92A0098FB1B1 | first-look-v5.1.json/records/207/official_access_mode | Historical; current review incomplete |
H51-019AC30990D44D109F4C3383 | first-look-v5.1.json/records/207/official_access_url | Historical; current review incomplete |
H51-8500A1BADFF233B8A42887B9 | first-look-v5.1.json/records/207/official_search_query | Historical; current review incomplete |
H51-67C225361578BD98DAFAC6B0 | first-look-v5.1.json/records/207/official_access_reason | Historical; current review incomplete |
H51-157BA35A65DF37EEF194C665 | preparation-assessments-v3.8.json/207/id | Historical; current review incomplete |
H51-3277DFD72ED20CD73B483609 | preparation-assessments-v3.8.json/207/name | Historical; current review incomplete |
H51-60D4BE364D8F65DB2025C8DD | preparation-assessments-v3.8.json/207/brands | Historical; current review incomplete |
H51-7925ADE6FCA0CE78267CDD0D | preparation-assessments-v3.8.json/207/therapeutic_class | Historical; current review incomplete |
H51-3159DD2563E9F01EDED9414D | preparation-assessments-v3.8.json/207/review_version | Historical; current review incomplete |
H51-924938BD41DDFD6C1B401AD3 | preparation-assessments-v3.8.json/207/review_date | Historical; current review incomplete |
H51-E4BFC3E49988DDB6CE44D20F | preparation-assessments-v3.8.json/207/release_status | Historical; current review incomplete |
H51-7D270AA42F5E6029B7EA72C8 | preparation-assessments-v3.8.json/207/market_status/status | Historical; current review incomplete |
H51-97117D3F7A990B3131AA3585 | preparation-assessments-v3.8.json/207/market_status/basis | Historical; current review incomplete |
H51-175B333F55C103320B06E6C4 | preparation-assessments-v3.8.json/207/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-40CC807AEB628042B41153F8 | preparation-assessments-v3.8.json/207/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-9E131B8EE17597D0F3545FB6 | preparation-assessments-v3.8.json/207/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-41AEA531AC7271691ADFC0A1 | preparation-assessments-v3.8.json/207/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-A3955D0FAF10AF27002E5E33 | preparation-assessments-v3.8.json/207/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-0E866F8AF0D3D77413C44EA3 | preparation-assessments-v3.8.json/207/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-714C0F65E041970523F88D3E | preparation-assessments-v3.8.json/207/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-DF9704F08687F3E6F03E813E | preparation-assessments-v3.8.json/207/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-7ADCC0F70A6B2E7CB1649120 | preparation-assessments-v3.8.json/207/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-98C9641E42816E24D0CCA780 | preparation-assessments-v3.8.json/207/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-79DEF39279FC1B091DB093C2 | preparation-assessments-v3.8.json/207/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-2C8CC8C9ACFF300236F027CF | preparation-assessments-v3.8.json/207/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-62ABCC5689F0F55FEBF276AF | preparation-assessments-v3.8.json/207/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-D94B86B9EE01BC5FBB45098B | preparation-assessments-v3.8.json/207/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-65BA2147BE3EE7721260CA31 | preparation-assessments-v3.8.json/207/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-E3DC6035FF0A975FB63F4962 | preparation-assessments-v3.8.json/207/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-DEC81D90E4D4795C2F99937E | preparation-assessments-v3.8.json/207/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-8B034038C0B3CC6B2D9A3A93 | preparation-assessments-v3.8.json/207/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-31B9D77F47A729CAD885EA5B | preparation-assessments-v3.8.json/207/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-F2AF8C2964039283D4A4D630 | preparation-assessments-v3.8.json/207/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-7912A2EAF8A93ED83FC64E0A | preparation-assessments-v3.8.json/207/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-53D55403C00A8F2F5A987B0F | preparation-assessments-v3.8.json/207/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-37240E82186C80118C1FEEB6 | preparation-assessments-v3.8.json/207/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-DFA9E0445E47288690BC1156 | preparation-assessments-v3.8.json/207/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-E6F6C00791E703B5B90BBDCE | preparation-assessments-v3.8.json/207/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-97CA7E077F04493D69C1A37F | preparation-assessments-v3.8.json/207/population_applicability/adult/applicability | Historical; current review incomplete |
H51-99CC1B3741CE666AE3897C2B | preparation-assessments-v3.8.json/207/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-069899991D4078B7A099535A | preparation-assessments-v3.8.json/207/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-095AD054B622970CB1B655F9 | preparation-assessments-v3.8.json/207/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-A4272E745D8E701D4FB036F9 | preparation-assessments-v3.8.json/207/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-7500756804D22799C4B5DCBC | preparation-assessments-v3.8.json/207/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-E480D233101C5B50561B13A8 | preparation-assessments-v3.8.json/207/route_presence/structured_dilution | Historical; current review incomplete |
H51-A4363F5F789E98F189EAAB7F | preparation-assessments-v3.8.json/207/route_presence/iv_push | Historical; current review incomplete |
H51-D2DD6CE54324F2D5E4FDB822 | preparation-assessments-v3.8.json/207/route_presence/continuous_infusion | Historical; current review incomplete |
H51-EBB02ADECC938BF73F495ACB | preparation-assessments-v3.8.json/207/route_presence/pediatric_source | Historical; current review incomplete |
H51-D3B99D89070FFA157ED90545 | preparation-assessments-v3.8.json/207/route_presence/neonatal_source | Historical; current review incomplete |
H51-B4664D400F522E00310CD7BC | preparation-assessments-v3.8.json/207/legacy_reference/status | Historical; current review incomplete |
H51-9AE9446F28447BCDE9213902 | preparation-assessments-v3.8.json/207/label_resolution/status | Historical; current review incomplete |
H51-56FB6F560A8516EEFB5A560B | preparation-assessments-v3.8.json/207/source_files/0 | Historical; current review incomplete |
H51-D03CEDD2D9CD62B7B078F886 | preparation-assessments-v3.8.json/207/source_files/1 | Historical; current review incomplete |
H51-A28385F57DA1A9E4602EFD46 | preparation-assessments-v3.8.json/207/source_files/2 | Historical; current review incomplete |
H51-994E710DF0FD6554E70FA1D9 | preparation-assessments-v3.8.json/207/source_files/3 | Historical; current review incomplete |
H51-EABF9F008C51E1C179F0E746 | preparation-assessments-v3.8.json/207/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)